Ligand validation:6TK3

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TK3_LFA_A_308	20%	73%	0.169	0.857	0.32	0.71	-	-	2	0	50%	0.5
6TK3_LFA_A_303	18%	74%	0.187	0.882	0.33	0.67	-	-	0	0	40%	0.26
6TK3_LFA_A_320	14%	79%	0.135	0.821	0.38	0.49	-	-	0	0	25%	0.25
6TK3_LFA_A_302	14%	72%	0.199	0.786	0.38	0.71	-	-	1	0	80%	0.8
6TK3_LFA_A_327	13%	73%	0.23	0.841	0.36	0.68	-	-	0	0	60%	0.6
6TK3_LFA_A_310	10%	70%	0.271	0.887	0.34	0.79	-	-	0	0	40%	0.4
6TK3_LFA_A_317	8%	72%	0.263	0.842	0.32	0.74	-	-	0	0	45%	0.45
6TK3_LFA_A_304	8%	79%	0.205	0.802	0.34	0.52	-	-	0	0	30%	0.3
6TK3_LFA_A_307	7%	71%	0.219	0.728	0.38	0.73	-	-	1	0	65%	0.65
6TK3_LFA_A_312	6%	70%	0.196	0.672	0.34	0.79	-	-	2	0	80%	0.8
6TK3_LFA_A_322	5%	80%	0.237	0.781	0.36	0.48	-	-	0	0	30%	0.3
6TK3_LFA_A_319	3%	81%	0.341	0.795	0.37	0.45	-	-	0	0	30%	0.3
6TK3_LFA_A_313	3%	79%	0.205	0.655	0.34	0.51	-	-	1	0	25%	0.25
6TK3_LFA_A_311	2%	72%	0.283	0.614	0.35	0.73	-	-	1	0	60%	0.6
6TK3_LFA_A_305	2%	79%	0.35	0.725	0.36	0.5	-	-	0	0	30%	0.3
6TK3_LFA_A_325	1%	74%	0.313	0.631	0.37	0.64	-	-	1	0	45%	0.45
6TK3_LFA_A_306	1%	79%	0.301	0.64	0.33	0.54	-	-	1	0	25%	0.25
6TK3_LFA_A_321	1%	70%	0.337	0.674	0.43	0.71	-	-	0	0	20%	0.2
6TK3_LFA_A_309	1%	76%	0.309	0.59	0.38	0.57	-	-	0	0	40%	0.4
6TK3_LFA_A_326	1%	76%	0.272	0.531	0.43	0.51	-	-	1	0	50%	0.5
6TK3_LFA_A_318	1%	78%	0.245	0.507	0.41	0.48	-	-	1	0	45%	0.45
6TK3_LFA_A_315	1%	83%	0.33	0.606	0.39	0.4	-	-	0	0	25%	0.25
6TK3_LFA_A_314	1%	76%	0.344	0.523	0.43	0.53	-	-	1	0	50%	0.5
6TK3_LFA_A_323	0%	73%	0.319	0.465	0.36	0.66	-	-	3	0	50%	0.5
6TK3_LFA_A_316	0%	73%	0.297	0.392	0.36	0.69	-	-	4	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	0.25
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	0.2
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	0	40%	0.4
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	0	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.